Trilok Pharma Private Limited
About Trilok Pharma Private Limited
Data last updated:
Trilok Pharma Private Limited is a private limited company based in Jabalpur, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 November 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U51100MP2019PTC049994. Its GSTIN is 23AAHCT5883G1Z3 (Madhya Pradesh).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors Manav Nandwani and Anil Kumar Nandwani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1358 Wright Town Rani Taal, Jabalpur, Madhya Pradesh, India – 482001.
As per the financials filed for FY 2025, the company reported a revenue of ₹59.67 Cr, a decline of 35% compared to the previous year. For the same year it recorded a net profit of ₹3.08 Cr (net margin 5.2%) and EBITDA of ₹6.22 Cr (EBITDA margin 10.4%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years and 60% over five years.
As per MCA filings, the company has open charges of ₹63.95 Cr and satisfied charges of ₹30.84 Cr on record. Court records list 1 case involving the company; 1 case is pending.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address1358 Wright Town Rani Taal, Jabalpur, Madhya Pradesh, India – 482001
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Trilok Pharma Private Limited
The main business activity of Trilok Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Trilok Pharma Private Limited FY 2025 filings available
Trilok Pharma Private Limited reported revenue of ₹59.67 Cr (down 35% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Trilok Pharma Private Limited
Revenue fell 35% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 60%. EBITDA fell 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Trilok Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹6.22 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.08 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Trilok Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 5.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Trilok Pharma are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Trilok Pharma Private Limited
Trilok Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vanvid Chemicals Private Limited | ₹59.73 Cr (FY 2024) | •••• | •••• | 8.0% | •••• | Mumbai, Maharashtra, India |
| Cadchem Laboratories Limited | ₹59.73 Cr (FY 2024) | •••• | •••• | -13.0% | •••• | Chandigarh, India |
| Sunshine Agri Private Limited | ₹59.73 Cr (FY 2024) | •••• | •••• | -15.0% | •••• | Jalgaon, Maharashtra, India |
| Macsen Labs Limited | ₹59.7 Cr (FY 2025) | •••• | •••• | -9.0% | •••• | Udaipur, Rajasthan, India |
| Systole Remedies Private Limited | ₹59.68 Cr (FY 2025) | •••• | •••• | 28.0% | •••• | Delhi, India |
| Trilok Pharma Private Limited this company | ₹59.67 Cr (FY 2025) | •••• | •••• | -35.0% | •••• | Jabalpur, Madhya Pradesh, India |
| Schevaran Laboratories Private Limited | ₹59.58 Cr (FY 2025) | •••• | •••• | 29.0% | •••• | Mysore, Karnataka, India |
| Bhasya International Private Limited | ₹59.51 Cr (FY 2024) | •••• | •••• | 124.0% | •••• | Hyderabad, Telangana, India |
| Om Tex Chem Limited | ₹59.51 Cr (FY 2024) | •••• | •••• | -7.0% | •••• | Mumbai, Maharashtra, India |
| Varad Crop Science Private Limited | ₹59.44 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Jalna, Maharashtra, India |
| Parb Pharmaceuticals Private Limited | ₹59.42 Cr (FY 2025) | •••• | •••• | 2461.0% | •••• | Dehradun, Uttarakhand, India |
Peers are the five companies nearest above and the five nearest below Trilok Pharma by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Trilok Pharma Private Limited
Trilok Pharma Private Limited is audited by Rahul & Co. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Rahul & Co. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Trilok Pharma Private Limited
Trilok Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manav Nandwani Also directs: Rabs Buildcon Private Limited, Preventra Nutrition Private Limited, Swaarnam Infraspace Private Limited and 1 more | Director | 05 Nov 2019 | 6 Years 11 Months | Current |
| Anil Kumar Nandwani Also directs: Real Water Fun Private Limited, Zorg Biotech Private Limited, Rabs Buildcon Private Limited and 4 more | Director | 20 Sep 2024 | 2 Years 0 Months | Current |
Ownership and Shareholding of Trilok Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Trilok Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Jul 2025 | Hdfc Bank Limited | ₹8.5 Cr | Open |
| 29 Nov 2023 | Hdfc Bank Limited | ₹10 Cr | Open |
| 31 Mar 2022 | Hdfc Bank Limited | ₹45 Cr | Open |
| 04 Dec 2021 | Hdfc Bank Limited | ₹45 Lakh | Open |
| 17 Dec 2024 | Others | ₹8 Lakh | Satisfied |
Total charge records: 7 View all charges
Legal Cases of Trilok Pharma Private Limited
Trilok Pharma Private Limited has 1 court case on record: 1 where it is another party. All case is pending. Status as checked on 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Jabalpur, Madhya Pradesh | Court case (RCS A) | Company is another party | Pending |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Trilok Pharma Private Limited
Employment history and EPFO contributions of people linked to Trilok Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Trilok Pharma Private Limited
Trilok Pharma has one previous CIN (Corporate Identification Number): U51909MP2019PTC049994. The current CIN is U51100MP2019PTC049994, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U51100MP2019PTC049994 | Current |
| U51909MP2019PTC049994 | Previous |
Recent Activity on Trilok Pharma Private Limited
Trilok Pharma Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Rajesh Nandwani ceased to be Director on 21 Sep 2024.
5 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Trilok Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Trilok Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Trilok Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Trilok Pharma Private Limited
Trilok Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAHCT5883G1Z3 | Madhya Pradesh | Active | 19 Feb 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Trilok Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Trilok Pharma Private Limited
Trilok Pharma is an active private limited company based in Jabalpur, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 November 2019 (7+ years old) and is registered under CIN U51100MP2019PTC049994.
Trilok Pharma reported revenue of ₹59.67 Cr for FY 2025 (down 35% YoY).
Trilok Pharma has 2 current directors:
- Manav Nandwani - Director
- Anil Kumar Nandwani - Director
Trilok Pharma reported a net profit of ₹3.08 Cr (net margin 5.2%) and EBITDA of ₹6.22 Cr (EBITDA margin 10.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Trilok Pharma is -20% over three years and 60% over five years. In the latest year (FY 2025) revenue fell 35%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Trilok Pharma is 23AAHCT5883G1Z3, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Trilok Pharma is U51100MP2019PTC049994. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Trilok Pharma has 1 court case on record. 1 is pending.
Trilok Pharma was incorporated on 05 November 2019, making it 7+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Trilok Pharma by revenue are Vanvid Chemicals Private Limited, Cadchem Laboratories Limited, Sunshine Agri Private Limited, Macsen Labs Limited, Systole Remedies Private Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rajesh Nandwani ceased to be Director on 21 Sep 2024. Anil Kumar Nandwani was appointed as Director on 20 Sep 2024. Manav Nandwani was appointed as Director on 05 Nov 2019.